Noel Mueller
Concepts (432)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Gastrointestinal Microbiome | 20 | 2024 | 538 | 8.260 |
Why?
| Cesarean Section | 13 | 2023 | 165 | 5.450 |
Why?
| Microbiota | 14 | 2023 | 655 | 5.140 |
Why?
| Delivery, Obstetric | 10 | 2022 | 125 | 4.460 |
Why?
| Adiposity | 10 | 2020 | 508 | 3.030 |
Why?
| Trace Elements | 4 | 2021 | 46 | 3.000 |
Why?
| Fatty Acids, Volatile | 7 | 2022 | 47 | 2.820 |
Why?
| Menarche | 7 | 2023 | 51 | 2.800 |
Why?
| Body Mass Index | 27 | 2023 | 2074 | 2.690 |
Why?
| Pre-Eclampsia | 5 | 2022 | 183 | 2.580 |
Why?
| Hypertension | 10 | 2022 | 1199 | 2.490 |
Why?
| Pregnancy | 36 | 2023 | 5672 | 2.340 |
Why?
| Pediatric Obesity | 11 | 2022 | 512 | 2.320 |
Why?
| Metals, Heavy | 3 | 2021 | 22 | 2.270 |
Why?
| Feces | 10 | 2023 | 392 | 2.260 |
Why?
| Prenatal Exposure Delayed Effects | 8 | 2020 | 465 | 2.030 |
Why?
| Mothers | 13 | 2023 | 675 | 2.030 |
Why?
| Vagina | 6 | 2023 | 150 | 1.760 |
Why?
| Diabetes Mellitus, Type 2 | 13 | 2022 | 2159 | 1.750 |
Why?
| Blood Pressure | 15 | 2022 | 1656 | 1.740 |
Why?
| Metformin | 5 | 2022 | 293 | 1.660 |
Why?
| Dietary Fiber | 3 | 2023 | 42 | 1.660 |
Why?
| Female | 92 | 2024 | 61266 | 1.630 |
Why?
| Dietary Approaches To Stop Hypertension | 3 | 2020 | 10 | 1.580 |
Why?
| Fetal Blood | 4 | 2022 | 270 | 1.570 |
Why?
| Carbonated Beverages | 3 | 2015 | 19 | 1.440 |
Why?
| Infant, Newborn | 19 | 2023 | 5230 | 1.430 |
Why?
| Dietary Carbohydrates | 3 | 2021 | 157 | 1.390 |
Why?
| Humans | 115 | 2024 | 118273 | 1.380 |
Why?
| Premature Birth | 2 | 2023 | 284 | 1.350 |
Why?
| Dietary Proteins | 2 | 2020 | 131 | 1.330 |
Why?
| Cardiovascular Diseases | 9 | 2022 | 1795 | 1.290 |
Why?
| Obesity | 15 | 2022 | 2715 | 1.270 |
Why?
| Longevity | 2 | 2019 | 150 | 1.240 |
Why?
| Infant | 22 | 2023 | 8254 | 1.190 |
Why?
| Adult | 52 | 2024 | 31325 | 1.160 |
Why?
| Methylamines | 2 | 2024 | 32 | 1.130 |
Why?
| Non-Nutritive Sweeteners | 2 | 2015 | 5 | 1.090 |
Why?
| Diet | 13 | 2024 | 1143 | 1.080 |
Why?
| Prospective Studies | 21 | 2022 | 6443 | 1.050 |
Why?
| Anti-Bacterial Agents | 5 | 2020 | 1514 | 1.000 |
Why?
| Male | 62 | 2024 | 57478 | 1.000 |
Why?
| Longitudinal Studies | 13 | 2024 | 2491 | 0.990 |
Why?
| Selenium | 2 | 2021 | 38 | 0.970 |
Why?
| Bacteria | 5 | 2023 | 751 | 0.940 |
Why?
| Infant Nutritional Physiological Phenomena | 3 | 2020 | 130 | 0.930 |
Why?
| Insulin Resistance | 6 | 2022 | 1167 | 0.930 |
Why?
| Sugars | 1 | 2023 | 32 | 0.930 |
Why?
| Child | 31 | 2023 | 19036 | 0.920 |
Why?
| Manganese | 2 | 2020 | 53 | 0.920 |
Why?
| Risk Factors | 30 | 2022 | 8957 | 0.910 |
Why?
| Leg | 2 | 2015 | 234 | 0.900 |
Why?
| Osteoporotic Fractures | 1 | 2023 | 50 | 0.890 |
Why?
| Blood Pressure Determination | 3 | 2019 | 133 | 0.840 |
Why?
| Diet, Mediterranean | 1 | 2022 | 20 | 0.840 |
Why?
| Overweight | 10 | 2021 | 492 | 0.840 |
Why?
| Chorioamnionitis | 1 | 2021 | 37 | 0.800 |
Why?
| Cross-Sectional Studies | 15 | 2024 | 4522 | 0.780 |
Why?
| Hypotension | 1 | 2022 | 119 | 0.770 |
Why?
| Sex Hormone-Binding Globulin | 1 | 2020 | 49 | 0.760 |
Why?
| Breast Feeding | 2 | 2023 | 381 | 0.760 |
Why?
| Fats, Unsaturated | 1 | 2020 | 1 | 0.740 |
Why?
| Dietary Fats, Unsaturated | 1 | 2020 | 22 | 0.730 |
Why?
| Weight Gain | 3 | 2018 | 485 | 0.730 |
Why?
| Diet, Sodium-Restricted | 2 | 2019 | 34 | 0.730 |
Why?
| Flatulence | 1 | 2019 | 2 | 0.710 |
Why?
| Dyspepsia | 1 | 2019 | 9 | 0.710 |
Why?
| Body Fluids | 1 | 2019 | 62 | 0.710 |
Why?
| Androgens | 1 | 2020 | 167 | 0.680 |
Why?
| Milk, Human | 1 | 2020 | 134 | 0.680 |
Why?
| Cohort Studies | 13 | 2023 | 5077 | 0.680 |
Why?
| Middle Aged | 35 | 2024 | 27512 | 0.670 |
Why?
| Pressure | 1 | 2020 | 226 | 0.670 |
Why?
| Abdominal Pain | 1 | 2020 | 133 | 0.660 |
Why?
| HTLV-I Infections | 8 | 2000 | 21 | 0.650 |
Why?
| Vitamin D Deficiency | 1 | 2020 | 161 | 0.650 |
Why?
| Disinfectants | 1 | 2018 | 33 | 0.650 |
Why?
| RNA, Ribosomal, 16S | 2 | 2020 | 507 | 0.640 |
Why?
| Vitamin D | 2 | 2023 | 352 | 0.640 |
Why?
| Boston | 6 | 2021 | 76 | 0.640 |
Why?
| Waist Circumference | 4 | 2016 | 130 | 0.630 |
Why?
| Estrogens | 1 | 2020 | 329 | 0.620 |
Why?
| Young Adult | 18 | 2021 | 10729 | 0.600 |
Why?
| Weight Loss | 5 | 2022 | 652 | 0.600 |
Why?
| Skinfold Thickness | 2 | 2018 | 46 | 0.600 |
Why?
| Birth Weight | 6 | 2018 | 463 | 0.600 |
Why?
| Non-alcoholic Fatty Liver Disease | 1 | 2020 | 277 | 0.590 |
Why?
| Sequence Analysis, DNA | 1 | 2020 | 748 | 0.590 |
Why?
| Age Factors | 6 | 2020 | 2990 | 0.580 |
Why?
| Rural Population | 3 | 2018 | 451 | 0.560 |
Why?
| Puberty | 2 | 2014 | 143 | 0.550 |
Why?
| Adolescent | 23 | 2022 | 18364 | 0.550 |
Why?
| Gastrointestinal Tract | 2 | 2015 | 174 | 0.550 |
Why?
| Singapore | 5 | 2013 | 15 | 0.540 |
Why?
| Infant Welfare | 1 | 2014 | 4 | 0.520 |
Why?
| Asthma | 3 | 2022 | 2143 | 0.520 |
Why?
| Brazil | 7 | 2016 | 107 | 0.510 |
Why?
| Child, Preschool | 12 | 2023 | 9448 | 0.510 |
Why?
| Abdominal Fat | 1 | 2014 | 48 | 0.500 |
Why?
| Leptin | 1 | 2016 | 228 | 0.490 |
Why?
| Adiponectin | 1 | 2016 | 224 | 0.490 |
Why?
| Health Status | 2 | 2023 | 723 | 0.480 |
Why?
| Baltimore | 2 | 2024 | 42 | 0.470 |
Why?
| Diabetes, Gestational | 2 | 2018 | 284 | 0.470 |
Why?
| Chronic Disease | 1 | 2019 | 1631 | 0.460 |
Why?
| Feeding Behavior | 2 | 2017 | 595 | 0.460 |
Why?
| Glucose | 2 | 2015 | 940 | 0.460 |
Why?
| Social Class | 1 | 2015 | 217 | 0.450 |
Why?
| Fetal Development | 1 | 2016 | 250 | 0.450 |
Why?
| Metabolic Syndrome | 4 | 2021 | 392 | 0.450 |
Why?
| Dyslipidemias | 1 | 2015 | 162 | 0.450 |
Why?
| Parity | 1 | 2013 | 100 | 0.450 |
Why?
| Wrist | 1 | 2013 | 51 | 0.440 |
Why?
| Aged | 19 | 2024 | 19597 | 0.440 |
Why?
| Linear Models | 6 | 2018 | 817 | 0.440 |
Why?
| Social Determinants of Health | 1 | 2015 | 127 | 0.440 |
Why?
| Anthropometry | 1 | 2013 | 192 | 0.440 |
Why?
| Bayes Theorem | 4 | 2021 | 341 | 0.430 |
Why?
| Liver | 1 | 2020 | 1804 | 0.430 |
Why?
| Fatty Liver | 1 | 2014 | 247 | 0.420 |
Why?
| Soy Foods | 1 | 2011 | 4 | 0.420 |
Why?
| Isoflavones | 1 | 2011 | 24 | 0.420 |
Why?
| Gestational Age | 3 | 2021 | 765 | 0.410 |
Why?
| Soybean Proteins | 1 | 2011 | 22 | 0.410 |
Why?
| Intra-Abdominal Fat | 1 | 2012 | 89 | 0.410 |
Why?
| Micronutrients | 2 | 2023 | 78 | 0.410 |
Why?
| Butyrates | 2 | 2022 | 54 | 0.390 |
Why?
| Obesity, Abdominal | 3 | 2016 | 39 | 0.390 |
Why?
| Intestinal Mucosa | 1 | 2015 | 529 | 0.370 |
Why?
| Bifidobacterium | 2 | 2021 | 22 | 0.360 |
Why?
| Probiotics | 2 | 2021 | 48 | 0.360 |
Why?
| Time Factors | 6 | 2020 | 6367 | 0.360 |
Why?
| Emigrants and Immigrants | 1 | 2012 | 115 | 0.360 |
Why?
| Child Health | 2 | 2023 | 136 | 0.350 |
Why?
| Metabolome | 2 | 2022 | 288 | 0.340 |
Why?
| Follow-Up Studies | 8 | 2018 | 4574 | 0.340 |
Why?
| Protective Factors | 3 | 2019 | 90 | 0.330 |
Why?
| Papillomavirus Vaccines | 1 | 2012 | 221 | 0.330 |
Why?
| Socioeconomic Factors | 6 | 2021 | 1122 | 0.330 |
Why?
| Papillomavirus Infections | 1 | 2012 | 263 | 0.320 |
Why?
| Quality of Life | 1 | 2019 | 2355 | 0.320 |
Why?
| Absorptiometry, Photon | 2 | 2023 | 226 | 0.320 |
Why?
| Beverages | 2 | 2023 | 70 | 0.320 |
Why?
| Women, Working | 2 | 2017 | 9 | 0.310 |
Why?
| Case-Control Studies | 6 | 2023 | 3155 | 0.310 |
Why?
| Risk Assessment | 4 | 2020 | 3042 | 0.300 |
Why?
| Logistic Models | 7 | 2023 | 1896 | 0.300 |
Why?
| Air Pollution | 2 | 2020 | 200 | 0.290 |
Why?
| Interviews as Topic | 3 | 2015 | 593 | 0.280 |
Why?
| Incidence | 7 | 2022 | 2413 | 0.280 |
Why?
| Body Size | 2 | 2018 | 94 | 0.280 |
Why?
| Prevalence | 9 | 2019 | 2321 | 0.280 |
Why?
| Blood Glucose | 5 | 2021 | 1937 | 0.270 |
Why?
| Sleep | 2 | 2023 | 651 | 0.270 |
Why?
| Infant, Low Birth Weight | 2 | 2016 | 125 | 0.270 |
Why?
| Emergency Medical Services | 1 | 2012 | 587 | 0.250 |
Why?
| Ohio | 2 | 2015 | 140 | 0.240 |
Why?
| Diet, Vegetarian | 1 | 2024 | 6 | 0.240 |
Why?
| Vitamins | 2 | 2023 | 157 | 0.240 |
Why?
| Homeostasis | 3 | 2016 | 589 | 0.240 |
Why?
| Research Design | 2 | 2021 | 961 | 0.240 |
Why?
| Severity of Illness Index | 3 | 2020 | 2659 | 0.230 |
Why?
| Vitamin A | 1 | 2023 | 55 | 0.230 |
Why?
| Health Knowledge, Attitudes, Practice | 1 | 2012 | 1183 | 0.230 |
Why?
| Nutrition Assessment | 2 | 2015 | 77 | 0.230 |
Why?
| Aging | 2 | 2024 | 1675 | 0.230 |
Why?
| Maternal Age | 1 | 2023 | 122 | 0.230 |
Why?
| Pancreatic Neoplasms | 1 | 2010 | 727 | 0.220 |
Why?
| Phthalic Acids | 1 | 2022 | 29 | 0.220 |
Why?
| Pregnancy Complications | 2 | 2018 | 448 | 0.210 |
Why?
| Sodium, Dietary | 2 | 2019 | 42 | 0.210 |
Why?
| District of Columbia | 3 | 2021 | 27 | 0.210 |
Why?
| Epidemiologic Studies | 1 | 2022 | 58 | 0.210 |
Why?
| Obesity Management | 1 | 2021 | 8 | 0.200 |
Why?
| Sodium | 2 | 2021 | 200 | 0.200 |
Why?
| Insulin-Like Growth Factor Binding Protein 3 | 1 | 2021 | 38 | 0.200 |
Why?
| Sex Characteristics | 2 | 2016 | 667 | 0.200 |
Why?
| Glycemic Index | 1 | 2021 | 23 | 0.200 |
Why?
| Regression Analysis | 3 | 2012 | 984 | 0.200 |
Why?
| Permeability | 1 | 2022 | 154 | 0.200 |
Why?
| Purines | 1 | 2022 | 160 | 0.200 |
Why?
| Cardiovascular System | 1 | 2023 | 127 | 0.200 |
Why?
| Observational Studies as Topic | 1 | 2021 | 88 | 0.200 |
Why?
| Clostridium perfringens | 1 | 2021 | 5 | 0.200 |
Why?
| Clostridium | 1 | 2021 | 15 | 0.200 |
Why?
| Bacteroides | 1 | 2021 | 17 | 0.200 |
Why?
| Environmental Pollutants | 1 | 2022 | 111 | 0.200 |
Why?
| Oxides | 1 | 2021 | 42 | 0.190 |
Why?
| Growth | 1 | 2021 | 58 | 0.190 |
Why?
| Smoking | 4 | 2013 | 1478 | 0.190 |
Why?
| Folic Acid | 2 | 2023 | 161 | 0.190 |
Why?
| Postpartum Period | 1 | 2023 | 267 | 0.190 |
Why?
| Health Impact Assessment | 1 | 2020 | 8 | 0.190 |
Why?
| Minority Groups | 1 | 2022 | 236 | 0.190 |
Why?
| Pregnancy Trimester, First | 1 | 2021 | 126 | 0.190 |
Why?
| Odds Ratio | 6 | 2023 | 993 | 0.190 |
Why?
| Massachusetts | 1 | 2020 | 141 | 0.180 |
Why?
| Dysbiosis | 1 | 2021 | 148 | 0.180 |
Why?
| DNA, Ribosomal | 1 | 2020 | 79 | 0.180 |
Why?
| Sex Factors | 4 | 2019 | 1765 | 0.180 |
Why?
| Skin Absorption | 1 | 2019 | 12 | 0.180 |
Why?
| HTLV-I Antibodies | 4 | 1992 | 5 | 0.180 |
Why?
| Vulnerable Populations | 1 | 2021 | 143 | 0.180 |
Why?
| Appetite | 1 | 2020 | 56 | 0.180 |
Why?
| United States | 8 | 2023 | 12495 | 0.180 |
Why?
| Interdisciplinary Research | 1 | 2020 | 26 | 0.180 |
Why?
| Hepatitis C | 2 | 2000 | 217 | 0.180 |
Why?
| Digestive System | 1 | 2019 | 29 | 0.170 |
Why?
| Mercury | 1 | 2019 | 29 | 0.170 |
Why?
| Cadmium | 1 | 2019 | 61 | 0.170 |
Why?
| Employment | 2 | 2017 | 133 | 0.170 |
Why?
| Insulin-Like Growth Factor I | 1 | 2021 | 285 | 0.170 |
Why?
| Lead | 1 | 2019 | 47 | 0.170 |
Why?
| Cholesterol, HDL | 1 | 2020 | 198 | 0.170 |
Why?
| Venezuela | 1 | 2018 | 7 | 0.170 |
Why?
| Behavior Therapy | 1 | 2021 | 236 | 0.170 |
Why?
| Men's Health | 1 | 2018 | 8 | 0.170 |
Why?
| Infectious Mononucleosis | 1 | 1998 | 9 | 0.170 |
Why?
| United States Food and Drug Administration | 1 | 2019 | 174 | 0.170 |
Why?
| Health Status Disparities | 1 | 2021 | 208 | 0.170 |
Why?
| Surveys and Questionnaires | 4 | 2014 | 4684 | 0.160 |
Why?
| DNA, Bacterial | 1 | 2020 | 313 | 0.160 |
Why?
| Dizziness | 1 | 2019 | 70 | 0.160 |
Why?
| Age Distribution | 2 | 2018 | 358 | 0.160 |
Why?
| Skin | 1 | 2023 | 657 | 0.160 |
Why?
| Age of Onset | 2 | 2016 | 465 | 0.160 |
Why?
| Cholesterol, LDL | 1 | 2020 | 316 | 0.160 |
Why?
| Biomarkers | 4 | 2022 | 3568 | 0.160 |
Why?
| Lipopolysaccharides | 1 | 2022 | 857 | 0.160 |
Why?
| Herpesvirus 4, Human | 1 | 1998 | 126 | 0.160 |
Why?
| Uric Acid | 1 | 2021 | 349 | 0.160 |
Why?
| Nutrition Surveys | 2 | 2021 | 232 | 0.160 |
Why?
| Liver Neoplasms | 2 | 2000 | 526 | 0.160 |
Why?
| Infant, Small for Gestational Age | 1 | 2018 | 73 | 0.160 |
Why?
| Pregnancy Complications, Cardiovascular | 1 | 2018 | 70 | 0.150 |
Why?
| Reference Values | 1 | 2019 | 770 | 0.150 |
Why?
| Computational Biology | 1 | 2021 | 541 | 0.150 |
Why?
| Leukocytes | 1 | 2018 | 284 | 0.150 |
Why?
| Verrucomicrobia | 1 | 2016 | 6 | 0.150 |
Why?
| Developing Countries | 2 | 2017 | 253 | 0.150 |
Why?
| Hodgkin Disease | 1 | 1998 | 119 | 0.150 |
Why?
| Colombia | 2 | 2016 | 43 | 0.150 |
Why?
| Clinical Trials as Topic | 2 | 2019 | 964 | 0.150 |
Why?
| Maternal Exposure | 1 | 2018 | 140 | 0.140 |
Why?
| Public Health | 1 | 2021 | 447 | 0.140 |
Why?
| Income | 1 | 2017 | 173 | 0.140 |
Why?
| Confidence Intervals | 2 | 2012 | 324 | 0.140 |
Why?
| Death | 1 | 2017 | 105 | 0.140 |
Why?
| Particulate Matter | 1 | 2018 | 234 | 0.140 |
Why?
| Phylogeny | 1 | 2020 | 817 | 0.140 |
Why?
| Preconception Care | 1 | 2016 | 28 | 0.140 |
Why?
| Autism Spectrum Disorder | 1 | 2020 | 324 | 0.140 |
Why?
| Pandemics | 2 | 2021 | 1338 | 0.140 |
Why?
| Aspartame | 1 | 2015 | 3 | 0.130 |
Why?
| Coffee | 1 | 2015 | 14 | 0.130 |
Why?
| Intestines | 1 | 2018 | 330 | 0.130 |
Why?
| Japan | 4 | 2000 | 97 | 0.130 |
Why?
| China | 1 | 2015 | 175 | 0.130 |
Why?
| Caffeine | 1 | 2015 | 61 | 0.130 |
Why?
| Nutrition Policy | 1 | 2015 | 57 | 0.130 |
Why?
| Elective Surgical Procedures | 1 | 2016 | 159 | 0.130 |
Why?
| Child Nutritional Physiological Phenomena | 1 | 2015 | 98 | 0.120 |
Why?
| Organ Size | 1 | 2015 | 460 | 0.120 |
Why?
| Body Weight | 1 | 2019 | 923 | 0.120 |
Why?
| Proportional Hazards Models | 2 | 2022 | 1124 | 0.120 |
Why?
| California | 1 | 2015 | 370 | 0.120 |
Why?
| Prognosis | 2 | 2019 | 3425 | 0.120 |
Why?
| Animals | 6 | 2023 | 33152 | 0.120 |
Why?
| Physical Examination | 1 | 2015 | 242 | 0.110 |
Why?
| Epidemiologic Methods | 1 | 2013 | 72 | 0.110 |
Why?
| Nutritional Status | 1 | 2015 | 298 | 0.110 |
Why?
| Oxidative Stress | 1 | 2019 | 1167 | 0.110 |
Why?
| Glucose Metabolism Disorders | 1 | 2012 | 12 | 0.110 |
Why?
| Diabetic Angiopathies | 1 | 2014 | 261 | 0.110 |
Why?
| Multivariate Analysis | 2 | 2017 | 1469 | 0.110 |
Why?
| Central America | 1 | 2012 | 27 | 0.100 |
Why?
| South America | 1 | 2012 | 56 | 0.100 |
Why?
| Abdomen | 1 | 2012 | 110 | 0.100 |
Why?
| Area Under Curve | 1 | 2012 | 293 | 0.100 |
Why?
| Analysis of Variance | 1 | 2015 | 1288 | 0.100 |
Why?
| Brain | 1 | 2023 | 2481 | 0.100 |
Why?
| Demography | 3 | 2017 | 273 | 0.100 |
Why?
| ROC Curve | 1 | 2012 | 469 | 0.100 |
Why?
| Cytokines | 1 | 2018 | 1880 | 0.090 |
Why?
| Occupations | 3 | 2017 | 37 | 0.090 |
Why?
| Dietary Sucrose | 1 | 2010 | 55 | 0.090 |
Why?
| Diabetes Mellitus | 2 | 2016 | 939 | 0.090 |
Why?
| Uterine Cervical Neoplasms | 1 | 2012 | 215 | 0.080 |
Why?
| Hypoglycemic Agents | 1 | 2016 | 1031 | 0.080 |
Why?
| Treatment Outcome | 2 | 2021 | 9319 | 0.080 |
Why?
| Dietary Supplements | 2 | 2023 | 467 | 0.080 |
Why?
| Health Promotion | 1 | 2015 | 685 | 0.080 |
Why?
| Predictive Value of Tests | 1 | 2013 | 1856 | 0.080 |
Why?
| India | 2 | 2021 | 141 | 0.080 |
Why?
| Smoking Cessation | 1 | 2011 | 359 | 0.070 |
Why?
| Patient Selection | 1 | 2011 | 670 | 0.070 |
Why?
| Human T-lymphotropic virus 1 | 2 | 1999 | 23 | 0.070 |
Why?
| Nucleoside-Triphosphatase | 1 | 2006 | 4 | 0.070 |
Why?
| RNA Helicases | 1 | 2006 | 20 | 0.070 |
Why?
| Flavivirus | 1 | 2006 | 16 | 0.070 |
Why?
| Muscle, Skeletal | 1 | 2015 | 1515 | 0.070 |
Why?
| Mice | 1 | 2022 | 15446 | 0.070 |
Why?
| Lipids | 2 | 2022 | 591 | 0.070 |
Why?
| Waist-Hip Ratio | 2 | 2016 | 31 | 0.070 |
Why?
| Health Services Accessibility | 1 | 2012 | 778 | 0.070 |
Why?
| Viral Nonstructural Proteins | 1 | 2006 | 59 | 0.070 |
Why?
| Tomography, X-Ray Computed | 1 | 2014 | 2433 | 0.060 |
Why?
| Insulin | 3 | 2021 | 2157 | 0.060 |
Why?
| Registries | 1 | 2012 | 1806 | 0.060 |
Why?
| Retrospective Studies | 3 | 2018 | 12931 | 0.060 |
Why?
| Vegetables | 1 | 2023 | 132 | 0.050 |
Why?
| Heartburn | 1 | 2021 | 11 | 0.050 |
Why?
| Maryland | 1 | 2021 | 36 | 0.050 |
Why?
| Iron | 1 | 2023 | 246 | 0.050 |
Why?
| Nutritional Requirements | 1 | 2021 | 74 | 0.050 |
Why?
| American Heart Association | 1 | 2023 | 270 | 0.050 |
Why?
| Hunger | 1 | 2021 | 46 | 0.050 |
Why?
| City Planning | 1 | 2020 | 1 | 0.050 |
Why?
| Africa, Eastern | 1 | 2020 | 11 | 0.050 |
Why?
| Gout | 1 | 2021 | 56 | 0.050 |
Why?
| Body Composition | 2 | 2015 | 644 | 0.050 |
Why?
| Transportation | 1 | 2020 | 42 | 0.050 |
Why?
| Causality | 1 | 2020 | 109 | 0.050 |
Why?
| Cities | 1 | 2020 | 96 | 0.050 |
Why?
| Capital Financing | 1 | 2020 | 6 | 0.050 |
Why?
| Tuberculin | 1 | 1999 | 6 | 0.040 |
Why?
| Personal Satisfaction | 1 | 2021 | 183 | 0.040 |
Why?
| Mentoring | 1 | 2021 | 101 | 0.040 |
Why?
| Lipoproteins, HDL | 1 | 2019 | 82 | 0.040 |
Why?
| Meconium | 1 | 2018 | 7 | 0.040 |
Why?
| Viral Matrix Proteins | 1 | 1998 | 24 | 0.040 |
Why?
| Lipoproteins, LDL | 1 | 2019 | 138 | 0.040 |
Why?
| Oncogene Proteins, Viral | 1 | 1998 | 20 | 0.040 |
Why?
| Environmental Exposure | 1 | 2022 | 398 | 0.040 |
Why?
| Th1 Cells | 1 | 1999 | 132 | 0.040 |
Why?
| Diet, Western | 1 | 2019 | 69 | 0.040 |
Why?
| Pregnancy Trimester, Third | 1 | 2018 | 69 | 0.040 |
Why?
| Virus Latency | 1 | 1998 | 80 | 0.040 |
Why?
| Cholesterol | 1 | 2019 | 375 | 0.040 |
Why?
| Cancer Survivors | 1 | 2021 | 201 | 0.040 |
Why?
| Metabolic Diseases | 1 | 2018 | 103 | 0.040 |
Why?
| Immunologic Memory | 1 | 1999 | 312 | 0.040 |
Why?
| Sex Distribution | 2 | 2014 | 347 | 0.040 |
Why?
| Calcium | 1 | 2023 | 1151 | 0.040 |
Why?
| Triglycerides | 1 | 2019 | 515 | 0.040 |
Why?
| Mucins | 1 | 2016 | 59 | 0.040 |
Why?
| Deltaretrovirus Antibodies | 1 | 1996 | 1 | 0.030 |
Why?
| Sarcoma, Kaposi | 1 | 1997 | 73 | 0.030 |
Why?
| Nutritional Physiological Phenomena | 1 | 2016 | 54 | 0.030 |
Why?
| Databases, Factual | 1 | 2021 | 1196 | 0.030 |
Why?
| Environmental Monitoring | 1 | 2018 | 295 | 0.030 |
Why?
| Health Care Costs | 1 | 2019 | 390 | 0.030 |
Why?
| Pregnancy Outcome | 1 | 2018 | 350 | 0.030 |
Why?
| Health Surveys | 1 | 2017 | 453 | 0.030 |
Why?
| Health Behavior | 1 | 2021 | 714 | 0.030 |
Why?
| Ambulatory Care | 1 | 2019 | 481 | 0.030 |
Why?
| Disease Transmission, Infectious | 1 | 1996 | 56 | 0.030 |
Why?
| Educational Status | 1 | 2017 | 437 | 0.030 |
Why?
| Carrier State | 1 | 1996 | 57 | 0.030 |
Why?
| Dominican Republic | 1 | 2015 | 19 | 0.030 |
Why?
| RNA, Viral | 1 | 1998 | 568 | 0.030 |
Why?
| New York | 1 | 2015 | 113 | 0.030 |
Why?
| Aged, 80 and over | 4 | 1997 | 6541 | 0.030 |
Why?
| Gene Products, tax | 2 | 1991 | 9 | 0.030 |
Why?
| Body Fat Distribution | 1 | 2014 | 45 | 0.030 |
Why?
| Hepatitis B | 1 | 1995 | 52 | 0.030 |
Why?
| Hyperlipidemias | 1 | 2015 | 127 | 0.030 |
Why?
| Randomized Controlled Trials as Topic | 1 | 2019 | 1237 | 0.030 |
Why?
| Poverty | 1 | 2017 | 444 | 0.030 |
Why?
| Communication | 1 | 2020 | 754 | 0.030 |
Why?
| Glucose Tolerance Test | 1 | 2015 | 361 | 0.030 |
Why?
| Carcinoma, Hepatocellular | 1 | 1995 | 227 | 0.030 |
Why?
| Colorado | 1 | 2023 | 4178 | 0.030 |
Why?
| Sensitivity and Specificity | 1 | 2017 | 1787 | 0.030 |
Why?
| Serologic Tests | 1 | 1992 | 52 | 0.030 |
Why?
| Forestry | 1 | 1992 | 4 | 0.030 |
Why?
| Fisheries | 1 | 1992 | 3 | 0.030 |
Why?
| Leukemia, T-Cell | 1 | 1991 | 4 | 0.030 |
Why?
| Toxoplasmosis | 1 | 1992 | 31 | 0.030 |
Why?
| DNA | 1 | 2018 | 1385 | 0.030 |
Why?
| Hyperglycemia | 1 | 2015 | 313 | 0.030 |
Why?
| Reproducibility of Results | 1 | 2018 | 2857 | 0.020 |
Why?
| Agriculture | 1 | 1992 | 88 | 0.020 |
Why?
| Hospitalization | 1 | 2019 | 1778 | 0.020 |
Why?
| Sexually Transmitted Diseases | 1 | 1991 | 153 | 0.020 |
Why?
| Neoplasms | 1 | 2021 | 2160 | 0.020 |
Why?
| Phenotype | 1 | 2014 | 2937 | 0.020 |
Why?
| Health Personnel | 1 | 1992 | 579 | 0.020 |
Why?
| Molecular Sequence Data | 2 | 2006 | 2855 | 0.020 |
Why?
| Sequence Homology, Amino Acid | 1 | 2006 | 367 | 0.020 |
Why?
| Recombinant Proteins | 2 | 1999 | 1302 | 0.010 |
Why?
| Amino Acid Sequence | 1 | 2006 | 2063 | 0.010 |
Why?
| Tritium | 1 | 1999 | 70 | 0.010 |
Why?
| Mycobacterium bovis | 1 | 1999 | 11 | 0.010 |
Why?
| Thymidine | 1 | 1999 | 62 | 0.010 |
Why?
| BCG Vaccine | 1 | 1999 | 25 | 0.010 |
Why?
| Interleukin-12 | 1 | 1999 | 110 | 0.010 |
Why?
| Antigens, Bacterial | 1 | 1999 | 116 | 0.010 |
Why?
| Antigens, Viral | 1 | 1999 | 178 | 0.010 |
Why?
| Interleukin-2 | 1 | 1999 | 416 | 0.010 |
Why?
| Blotting, Western | 2 | 1991 | 1186 | 0.010 |
Why?
| Cell Division | 1 | 1999 | 775 | 0.010 |
Why?
| Greece | 1 | 1997 | 7 | 0.010 |
Why?
| Interferon-gamma | 1 | 1999 | 735 | 0.010 |
Why?
| Acquired Immunodeficiency Syndrome | 1 | 1997 | 219 | 0.010 |
Why?
| Hepatitis Antibodies | 1 | 1995 | 1 | 0.010 |
Why?
| Hepatitis B Surface Antigens | 1 | 1995 | 19 | 0.010 |
Why?
| Hepatitis B virus | 1 | 1995 | 25 | 0.010 |
Why?
| Otorhinolaryngologic Diseases | 1 | 1995 | 16 | 0.010 |
Why?
| Seroepidemiologic Studies | 1 | 1995 | 146 | 0.010 |
Why?
| Eye Diseases | 1 | 1995 | 78 | 0.010 |
Why?
| Hepacivirus | 1 | 1995 | 230 | 0.010 |
Why?
| Life Style | 1 | 1995 | 431 | 0.010 |
Why?
| Blood Transfusion | 1 | 1995 | 278 | 0.010 |
Why?
| Retroviruses, Simian | 1 | 1991 | 1 | 0.010 |
Why?
| HTLV-I Antigens | 1 | 1991 | 1 | 0.010 |
Why?
| Genes, pX | 1 | 1991 | 2 | 0.010 |
Why?
| Papio | 1 | 1991 | 92 | 0.010 |
Why?
| Cells, Cultured | 1 | 1999 | 4044 | 0.010 |
Why?
| Agglutination Tests | 1 | 1991 | 2 | 0.010 |
Why?
| Radioimmunoprecipitation Assay | 1 | 1990 | 6 | 0.010 |
Why?
| Radioimmunoassay | 1 | 1991 | 164 | 0.010 |
Why?
| Lymphocytes | 1 | 1991 | 347 | 0.010 |
Why?
| DNA, Viral | 1 | 1991 | 351 | 0.010 |
Why?
| Antibody Formation | 1 | 1991 | 275 | 0.010 |
Why?
| Alcohol Drinking | 1 | 1995 | 651 | 0.010 |
Why?
| Polymerase Chain Reaction | 1 | 1991 | 1004 | 0.010 |
Why?
| Enzyme-Linked Immunosorbent Assay | 1 | 1990 | 817 | 0.010 |
Why?
| Antibodies, Viral | 1 | 1991 | 538 | 0.000 |
Why?
| Family | 1 | 1991 | 578 | 0.000 |
Why?
| Base Sequence | 1 | 1991 | 2148 | 0.000 |
Why?
| Postoperative Complications | 1 | 1995 | 2230 | 0.000 |
Why?
|
|
Mueller's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|